Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

European Urology

Volumn 72, Issue 5, 2017, Pages 801-813

  Soukup, Viktor ^a   Čapoun, Otakar ^a   Cohen, Daniel ^b   Hernández, Virginia ^c   Babjuk, Marek ^d   Burger, Max ^e   Compérat, Eva ^f   Gontero, Paolo ^g   Lam, Thomas ^h,i   MacLennan, Steven ^h   Mostafid, A Hugh ^j   Palou, Joan ^k   van Rhijn, Bas W G ^l   Rouprêt, Morgan ^f   Shariat, Shahrokh F ^m   Sylvester, Richard ⁿ   Yuan, Yuhong ^o   Zigeuner, Richard ^p  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^j ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^m UNIVERSITY OF VIENNA   (Austria)

ⁿ Italy   (Netherlands)

^o MCMASTER UNIVERSITY   (Canada)

^p MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

1973 World Health Organization classification; 2004 2016 World Health Organization classification; Grade; Non muscle invasive bladder cancer; Prognosis; Progression; Recurrence; Repeatability; Reproducibility

Indexed keywords

ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; HUMAN; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; BLADDER TUMOR; CLASSIFICATION; COMPARATIVE STUDY; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; METASTASIS; MORTALITY; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; STANDARDS; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE;

DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 85018192017     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2017.04.015     Document Type: Article

References (43)

1. Millan-Rodriguez, F., Chechile-Toniolo, G., Salvador-Bayarri, J., et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000), 73–78.
2. Sylvester, R.J., van der Meijden, A., Oosterlinck, W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006), 466–477.
3. van Rhijn, B.W., van Leenders, G.J., Ooms, B.C., et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur Urol 57 (2010), 1052–1057.
4. Babjuk, M., Böhle, A., Burger, M., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71 (2017), 447–461.
5. Mostofi, F.K., Sobin, L.H., Torloni, H., (eds.) Histological typing of urinary bladder tumours, 1973, World Health Organization, Geneva, Switzerland.
6. Bol, M.G., Baak, J.P., Buhr-Wildhagen, S., et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 169 (2003), 1291–1294.
7. Epstein, J.I., Amin, M.B., Reuter, V.R., et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22 (1998), 1435–1438.
8. Eble, J.N., Sauter, G., Epstein, J.I., et al. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. 2004, IARC Press, Lyon, France.
9. Moch, H., Humphrey, P.A., Ulbright, T.M., Reuter, V.E., WHO classification of tumours of the urinary system and male genital organs. ed. 4, 2016, WHO, Lyon, France.
10. Yorukoglu, K., Tuna, B., Dikicioglu, E., et al. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 443 (2003), 734–740.
11. Hayden, J.A., van der Windt, D.A., Cartwright, J.L., et al. Assessing bias in studies of prognostic factors. Ann Intern Med 158 (2013), 280–286.
12. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
13. Fleiss, J.L., Levin, B., Paik, M.C., Statistical methods for rates and proportions. ed. 3, 2003, John Wiley & Sons, New York, NY.
14. Mangrud, O.M., Gudlaugsson, E., Skaland, I., et al. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder. Hum Pathol 45 (2014), 1496–1503.
15. Holmäng, S., Hedelin, H., Anderström, C., et al. Recurrence and progression in low grade papillary urothelial tumors. J Urol 162 (1999), 702–707.
16. Mangrud, O.M., Waalen, R., Gudlaugsson, E., et al. Reproducibility and prognostic value of WHO 1973 and WHO 2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder. PLoS One, 9, 2014, e83192.
17. Holmäng, S., Andius, P., Hedelin, H., et al. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165 (2001), 1124–1128.
18. Gontero, P., Gillo, A., Fiorito, C., et al. Prognostic factors of ‘high-grade’ Ta bladder cancers according to the WHO 2004 classification: are these equivalent to ‘high-risk’ non-muscle-invasive bladder cancer?. Urol Int 92 (2014), 136–142.
19. Nishiyama, N., Kitamura, H., Maeda, T., et al. Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system. Jpn J Clin Oncol 43 (2013), 1124–1131.
20. Chen, Z., Ding, W., Xu, K., et al. The 1973 WHO Classification is more suitable than the 2004 WHO classification for predicting prognosis in non-muscle-invasive bladder cancer. PLoS One, 7, 2012, e47199.
21. Pellucchi, F., Freschi, M., Ibrahim, B., et al. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. J Urol 186 (2011), 2194–2199.
22. Pellucchi, F., Freschi, M., Moschini, M., et al. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?. BJU Int 115 (2015), 267–273.
23. Otto, W., Denzinger, S., Fritsche, H.M., et al. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int 107 (2011), 404–408.
24. Ishida, R., Tsuzuki, T., Yoshida, S., et al. Clinicopathological study of the 1973 who classification and the WHO/ISUP classification in pTa bladder carcinoma. Nihon Hinyokika Gakkai Zasshi 101 (2010), 609–614.
25. van Rhijn, B.W., van der Kwast, T.H., Kakiashvili, D.M., et al. Pathological stage review is indicated in primary pT1 bladder cancer. BJU Int 106 (2010), 206–211.
26. Burger, M., Denzinger, S., Wieland, W.F., et al. Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?. BJU Int 102 (2008), 194–197.
27. Burger, M., van der Aa, M.N., van Oers, J.M., et al. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol 54 (2008), 835–843.
28. Schned, A.R., Andrew, A.S., Marsit, C.J., et al. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J Urol 178 (2007), 1196–1200.
29. Kamel, M.H., Daly, P.J., Khan, M.F., et al. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma. Eur J Surg Oncol 32 (2006), 1139–1143.
30. Yin, H., Leong, A.S., Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 121 (2004), 679–687.
31. Oosterhuis, J.W., Schapers, R.F., Janssen-Heijnen, M.L., et al. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 55 (2002), 900–905.
32. Samaratunga, H., Makarov, D.V., Epstein, J.I., Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 60 (2002), 315–319.
33. May, M., Brookman-Amissah, S., Roigas, J., et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol 57 (2010), 850–858.
34. van Rhijn, B.W., Musquera, M., Liu, L., et al. Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. Mod Pathol 28 (2015), 695–705.
35. Epstein, J.I., The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?. Crit Rev Oncol Hematol 47 (2003), 83–89.
36. MacLennan, G.T., Kirkali, Z., Cheng, L., Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 51 (2007), 889–897.
37. Gonzalez-Campora, G., Davalos-Casanova, A., Beato-Moreno, R.J., et al. Apoptotic and proliferation indexes in primary superficial bladder tumors. Cancer Lett 242 (2006), 266–272.
38. Pauwels, R.F., Schapers, A.W., Smeets, F.M., et al. Grading in superficial bladder cancer. Morphological criteria. Br J Urol 61 (1988), 129–134.
39. Liedberg, F., Lauss, M., Patschan, O., et al. The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading. Eur Urol 62 (2012), 620–623.
40. Lokeshwar, S.D., Ruiz-Cordero, R., Hupe, M.C., et al. Impact of 2004 ISUP/WHO classification on bladder cancer grading. World J Urol 33 (2015), 1929–1936.
41. Engers, R., Reproducibility and reliability of tumor grading in urological neoplasms. World J Urol 25 (2007), 595–605.
42. Montironi, R., Lopez-Beltran, A., Scarpelli, M., et al. 2004 World Health Organization classification of the noninvasive urothelial neoplasms: inherent problems and clinical reflections. Eur Urol Suppl 8 (2009), 453–457.
43. Mikulowski, P., Hellsten, S., T1 G1 urinary bladder carcinoma: fact or fiction?. Scand J Urol Nephrol 39 (2005), 135–137.